Lin Xiaoyan, Cai Fengfeng, Li Xiaoyan, Kong Xiaoli, Xu Cheng, Zuo Xiaoming, Yang Qifeng
Department of Oncology, Qilu Hospital, Shandong University, Jinan, 250012, Shandong, China,
Tumour Biol. 2013 Oct;34(5):3239-43. doi: 10.1007/s13277-013-0895-8. Epub 2013 Jun 6.
Mammalian sterile 20-like kinase 1 (Mst1) has been proved in the process of apoptosis and tumor suppression. The aim of the study was to investigate the expression of Mst1 in breast cancer and to evaluate its prognostic significance. The expression of Mst1 was examined in 110 breast cancer patients by immunohistochemistry, in which 80 (72.7 %) were defined as positive for Mst1 expression. Patients with negative expression of Mst1 had poor overall survival, comparing with those with positive expression using Kaplan-Meier survival analysis (P = 0.009). Multivariate analysis using Cox proportional hazards model showed that Mst1 expression was a significant independent prognostic factor in breast cancer (P = 0.030). Our results presented the tumor suppressive role of Mst1, and confirmed Mst1 was a prognostic factor in human breast cancer.
哺乳动物不育20样激酶1(Mst1)已被证实在细胞凋亡和肿瘤抑制过程中发挥作用。本研究旨在探讨Mst1在乳腺癌中的表达情况,并评估其预后意义。采用免疫组织化学方法检测了110例乳腺癌患者中Mst1的表达,其中80例(72.7%)Mst1表达为阳性。通过Kaplan-Meier生存分析发现,Mst1表达阴性的患者总生存期较差,与阳性表达患者相比差异有统计学意义(P = 0.009)。使用Cox比例风险模型进行多因素分析显示,Mst1表达是乳腺癌的一个显著独立预后因素(P = 0.030)。我们的结果表明了Mst1的肿瘤抑制作用,并证实Mst1是人类乳腺癌的一个预后因素。